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Abstract 
Background: Heterosexual transmission remains the main route of HIV-1 transmission and female genital tract (FGT) 
inflammation increases the risk of infection. However, the mechanism(s) by which inflammation facilitates infection is 
not fully understood. In rhesus macaques challenged with simian immunodeficiency virus, dendritic cell (DC) medi-
ated recruitment of CD4+ T cells to the FGT was critical for infection. The aim of this study was to delineate the mech-
anisms underlying DC-mediated HIV infection by comparing chemokine and pro-inflammatory cytokine production 
in response to transmitted founder (TF) and chronic infection (CI) Envelope (Env) pseudotyped viruses (PSV).
Results: Monocyte-derived DCs (MDDCs) were stimulated with PSV and recombinant gp140 representing matched 
TF and CI pairs of four individuals and cytokine secretion measured by multiplex immuno-assay. We found that 4/9 
Env induced robust MDDC inflammatory responses and of those, three were cloned from TFs. Overall, TF Env induced 
MDDCs from healthy donors to secrete higher concentrations of inflammatory cytokines and chemokines than those 
from CI, suggesting TF Env were better inducers of inflammation. Assessing the signalling pathway associated with 
inflammatory cytokines, we found that PSV of matched TF and CI variants and a gp140 clone activated ERK and JNK to 
similar levels. Recombinant soluble DC-SIGN inhibited cytokine release and activation of ERK by PSV, suggesting that 
Env-DC-SIGN binding was partly involved in MDDC stimulation. Therefore, Env clones might differentially stimulate 
MDDC immune responses via alternative, yet unidentified signalling pathways.
Conclusion: Overall, this could suggest that the genetics of the virus itself influences inflammatory responses dur-
ing HIV infection. In the absence of pre-existing infections, induction of greater inflammatory response by TFs might 
favour virus survival within the healthy FGT by driving an influx of target cells to sites of infection while suppressing 
immune responses via IL-10.
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Background
Inflammation of the female genital tract (FGT) facili-
tates HIV-1 transmission [1–3]. This could be because 
of mechanical damage to the protective mucosal barrier 
or the influx of T cells, macrophages and dendritic cells 
(DCs) to the FGT mucosa [2, 4]. Recruitment of HIV-
permissive cells to the FGT might allow for rapid infec-
tion, transport to lymph nodes and unchecked viral 
replication. Haaland et  al. [2] found that infection by 
multiple variants was associated with FGT inflamma-
tion. However, in the vast majority of cases, productive 
clinical infection is due to a single variant, the transmit-
ted founder (TF) despite the presence of multiple vari-
ants in the donor [5, 6]. These findings suggest that not 
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all variants are able to overcome an intact mucosal bar-
rier and it has long been hypothesised that TF Envelope 
(Env) might provide a selective advantage during trans-
mission. A number of studies [7, 8] to identify the elusive 
transmission motif have thus far suggested that only R5 
tropism and potentially some Env N-glycosylation might 
consistently be associated with TFs [9–12]. The link 
between FGT inflammation, infection by TFs in the pres-
ence of an intact mucosal barrier and Env structure and 
function has yet to be elucidated.
In a previous study, when rhesus macaques were inocu-
lated with simian immunodeficiency virus (SIV), DCs 
secreted inflammatory cytokines and chemokines (IFN-γ 
MIP-1α, MIP-1β, and MIP-3 α,) that recruited CCR5+ 
target cells to the local mucosa leading to enhanced infec-
tion [13]. Moreover, when DC inflammatory immune 
responses (IR) were inhibited using anti-inflammatory 
glycerol monolaurate, animals were protected against 
SIV infection [13]. This suggested that similar to other 
pathogens, HIV-1 deregulation of DC cytokine secretion 
might play an important role in transmission [14, 15].
It was also found that when HIV-1 Env binds to DC-
SIGN it triggers trans-infection of CD4+ T cells, dereg-
ulation of DC function, prevention of DC maturation 
and inhibition of IL-12 expression [16–18]. In addition, 
when monocyte derived DCs (MDDCs) were exposed to 
HIV-1, IL-10 secretion [19, 20] was enhanced while the 
release of IL-12 and its capacity to stimulate T cell pro-
liferation was inhibited [21]. Cohort studies showed that 
concentrations of pro-inflammatory cytokines, IL-8, 
IL-1 and TNF-α, and pleiotropic cytokines such as IL-10 
and IL-6 were found to be abnormally high in plasma of 
HIV infected patients with a concomitant decrease in 
IL-2, IL-12 and IFN-γ levels [22–32]. Moreover, cervico-
vaginal lavages (CVL) of HIV infected women sampled 
within weeks of infection had significantly elevated lev-
els of IL-6, IL-10, and IL-12, compared to HIV negative 
women whereas, IL-1α, IL-1β, IL-8, IL-6, IP10 and IL-10 
were increased in plasma of the same patients [22, 33]. 
We had previously shown that MDDCs exposed to Env of 
TFs secreted higher levels of IL-10 than those stimulated 
with Env isolated from variants during chronic stages of 
infection (CI) [34]. To understand the role of HIV-1 sub-
type C Env in local inflammatory responses that might 
lead to new HIV infections, we investigated whether HIV 
subtype C Env isolated during acute infection (AI) and 
CI induce distinctive inflammatory responses in healthy 
MDDCs.
Previous findings suggested that binding of Env to DC-
SIGN triggered different signalling pathways which cul-
minated in alternative outcomes. For instance, HIV Env 
binding to MDDCs via DC-SIGN led to increased Rho-
GTPase activity required for the formation of virological 
synapses [35] whereas the expression of full-length HIV 
transcripts required Toll-like receptor-8 (TLR-8) [36]. 
Binding of gp120 to DC-SIGN led to IL-10 secretion via 
the activation and phosphorylation of ERK [37] and DC-
SIGN-mediated modulation of TLR-dependent activa-
tion of NF-kB [38]. Shan et al. [37] suggested that virus 
genetics influenced whether MDDCs secreted IL-10 after 
exposure to gp120. Furthermore, Wilflingseder et  al. 
[39] suggested that HIV-1 gp120 differentially activated 
ERK1/2 and p38 MAPK which lead to alternative DC 
phenotypes. Together, these findings suggested that dif-
ferent Env clones might differentially activate MAPKs, 
leading to alternative DC IR that either favour virus 
clearance or HIV-1 transmission. Therefore, this study 
hypothesised that in the absence of a pre-existing FGT 
inflammatory response TF Env modulates DC IR that ini-
tiate the recruitment of HIV-permissive cells, leading to 
productive clinical HIV infection.
Results
MDDC secretion of inflammatory cytokines 
and chemokines in response to HIV‑1
During an antigenic challenge, DCs secrete a combi-
nation of soluble mediators which together with co-
stimulatory molecules may influence the strength and 
breadth of the IR [40, 41]. Therefore, in addition to the 
anti-inflammatory cytokine IL-10 (Fig.  1a) [34], we also 
determined the effect of PSV on MDDC secretion of pro-
inflammatory cytokines (TNF-α, IL-6, IL-1β, IL-12p40) 
(Fig.  1b–e) and chemokines (MIP-1α, MIP-1β, IL-8) 
(Fig. 1f–h). MDDCs from healthy donors were stimulated 
with PSV of four TF (C1, C7, C12 and C15) and matched 
CI Env (C2, C8, C13, C14 and C16) and cytokines were 
measured by Luminex. Stimulation of IL-8 release was 
highly variable between donors in response to the differ-
ent clones and all PSV clones seemed to be poor inducers 
of IL-12p40 relative to the background control. On the 
other hand, C7, C12, C14 and C15 were better stimula-
tors of TNF-α, IL-6, MIP-1α, MIP-1β and IL-8 secretion 
than the negative control with the respective cytokine 
and chemokine concentrations ranging from 26–200, 
55–955; 845–1446; 80–361 and 7285–287,334  pg/mL. 
C7 and C12 induced the secretion of significantly higher 
concentrations of TNF-α (p = 0.0086, p = 0.0043) IL-6 
(p = 0.031, p = 0.031), MIP-1α (p = 0.055, p = 0.016) and 
IL-8 (p = 0.055, p = 0.031) (Fig. 1).
To determine overall inflammatory response patterns, 
hierarchical clustering and exploratory factor analy-
sis were performed of all the cytokines and chemokines 
induced by all PSV Env tested. Most of the cytokines 
clustered together in Factor 1, with pro-inflammatory 
cytokines (IL-6 and TNF-α), chemokines (MIP-1α and 
MIP-1β) and anti-inflammatory IL-10 grouping together 
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(Fig. 2a and Table 1). IL-8 and IL-1β were closely related 
and grouped together in Factor 2 (Table 1). Although IL-
12p40 clustered more closely with Factor 1 than Factor 
2, this cytokine had the greatest degree of uniqueness 
(Table  1) and clustered separately in the unsupervised 
hierarchical exploratory analysis (Fig. 2a). Therefore, the 
release of IL-6, TNF-α, MIP-1α, MIP-1β and IL-10 by 
MDDCs in response to PSV seemed to be linked. 
PSV clustered into two groups: those that tended to 
induce high levels of cytokines (upper three rows) and 
those that were weak stimulators of MDDC cytokine 
release (lower six rows) (Fig. 2a). PCA was used to gener-
ate principal component scores for each PSV, represent-
ing overall pro-inflammatory cytokine responses (TNF-α, 
IL-6, IL-1β) (Fig.  2b) and overall chemokine responses 
(MIP-1α, IL-8 and MIP-1β) (Fig.  2c). C1, C7, C12, C13, 
C14, and C15 had significantly higher pro-inflammatory 
component scores compared to the control (Fig. 2b I). Of 
these six clones, four represented TF variants whereas 
two were CI Env from the same participant. For the 
chemokine component scores, only C7 and C12, both TF, 
had significantly higher scores than controls after adjust-
ing for multiple comparisons (Fig. 2c I).
Fig. 1 HIV-1 subtype C Envelopes induce inflammatory immune response. Monocyte derived dendritic cells (MDDC) were stimulated with 
pseudovirus (PSV) of Envelopes (Env) cloned from variants infecting four participants during acute (TF, black bars) and chronic (CI, white bars) stages 
of infection. Levels of a IL-10, b TNF-α, c IL-6, d IL-1β, e IL-12p40 f MIP-1α, g MIP-1β, and h IL-8 in the culture supernatants of MDDC were measured 
by Luminex assay. PSV generated using pSG3∆Env only was used as negative control (Ctrl, grey bar). Mann–Whitney test was used to compare 
cytokine levels to the negative control and Wilcoxon Rank Signed test was used to compare paired Env from the same participant (TF vs CI). Bar 
graphs represent medians of each cytokine (pg/mL) concentration of 8, 7, 6, 5 and 5 biological repeats for IL-8, IL-10, TNF-α, IL-6 and chemokines, 
respectively. Error bars show standard deviations (SD). P-values were adjusted for multiple comparisons by the false discovery rate step-down 
procedure
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Transmitted founder Envelopes preferentially 
induced MDDC secretion of inflammatory cytokines 
and chemokines
Cytokine induction seemed to be associated with time 
post-infection as C7, C12 and to a lesser extent, C15, 
three of the four best inducers of cytokine release were 
cloned from TF variants (Fig. 1). For example, CAP206C7 
and CAP210C12, induced the secretion of more TNF-α 
(p = 0.013) and IL-6 (p = 0.06) than their matched CI 
clones, CAP206C8, CAP210C13 and CAP210C14 
(Fig.  1b, c). Furthermore, TF Env seemed to be better 
inducers of inflammation as all TF clones, C1, C7, C12, 
and C15 had higher pro-inflammatory component scores 
than the control (Fig.  2b) and TFs C7 and C12 proin-
flammatory scores were significantly greater than their 
corresponding CI (p = 0.0152 and 0.0043 respectively). 
Only C12 had a significantly higher chemokine score 
(p = 0.028) than its matched CI counterpart (Fig. 2a). In 
addition, only TF PSV had a tendency to induce IL-1β 
although this did not reach significance. When clones 
were grouped according to time of sampling, both the 
pro-inflammatory (Fig. 2b II) and chemokine (Fig. 2c II) 
component scores of TF and CI clones were significantly 
higher than the controls and TF values were greater than 
that of the CI clones, although the difference did not 
reach significance.
To circumvent experimental and donor variation 
between biological repeats, PSV were grouped into TF 
and CI variants and the concentration of each cytokine 
was expressed relative to the background of each bio-
logical repeat before comparing the median values. Over-
all, TF PSV were better at inducing each cytokine than 
their matched CI clone. MDDCs stimulated with TF Env 
tended to release two–eightfold higher concentrations 
of all cytokines, compared to levels induced by CI PSV 
that increased by only two–fourfold above background 
(Fig. 3).
The role of DC‑SIGN in MDDC secretion of inflammatory 
cytokines and chemokines
In a previous study we stimulated MDDCs with PSV in 
the presence of recombinant DC-SIGN to determine 
whether IL-10 release was due to Env-DC-SIGN binding. 
DC-SIGN inhibition was shown to lower the secretion of 
IL-10 by MDDCs [34]. As pro-inflammatory cytokines 
and some chemokines grouped together with IL-10 in the 
hierarchical clustering, we determined whether recombi-
nant DC-SIGN would also inhibit the release of the other 
inflammation modulators. Two matched clones (C12 and 
C13) were selected that represented the best and weakest 
inducers of proinflammatory cytokines and chemokines. 
Inhibition of C12 PSV DC-SIGN interaction with recom-
binant DC-SIGN significantly reduced MDDC secretion 
of IL-6 and TNF-α levels while inhibition of chemokine 
secretion did not reach statistical significance (Fig.  4). 
On the contrary, inhibition of MDDC cytokine and 
chemokine secretion in response to C13, the matched 
CI clone of C12, was not observed. This is likely due 
to C13 being a very poor inducer of all cytokines and 
chemokines, limiting the detection of changes in cytokine 
and chemokine concentrations in the presence of recom-
binant DC-SIGN. However, we cannot exclude that 
preparation of recombinant protein did not co-purify 
contaminants or alter the structure of soluble DC-SIGN 
which might have influenced its binding to Env. Despite 
these limitations, apparent inhibition of cytokine release 
in the presence of recombinant DC-SIGN suggests that 
DC-SIGN-Env interactions are important.
Envelope activation of MAPK kinase signalling
As TF and CI PSV seemed to differ in their ability to 
induce MDDC secretion of cytokines and chemokines, 
we hypothesized that differences in Env structure might 
activate either alternative signaling pathways or elicit 
a more robust response due to higher affinity binding 
(See figure on next page.)
Fig. 2 Envelope clones cluster into two groups according to inflammatory immune response. a Unsupervised hierarchical clustering (in R) was 
used to visualize all 9 differentially released cytokine concentrations secreted in response to pseudovirus (PSV) stimulation of MDDCs, and to cluster 
different Envelope (Env) clones according to similarity of their cytokine expression profiles irrespective of their sequence and cytokine function. 
Cytokine concentrations are indicated using a colour scale, ranging from blue (low), through white, to red (high). The dendrogram above the heat 
map illustrates degrees of relatedness between cytokines, while the dendrogram on the left illustrates Env clusters according to their capacity to 
induce cytokine secretion. The identity of the Env clones are indicated on the right of the heat map with transmitted founder (TF) and chronic 
infection (CI) clones indicated by black and white keys, respectively. Cytokines were grouped according to whether they were b pro-inflammatory 
(IL-1β, TNF-α, IL-6) or c chemokines (MIP-1α, MIP-1β and IL-8) and inflammatory cytokine component scores were generated using principal 
component analysis and plotted as bar graphs. The pro-inflammatory I) and chemotactic II) component scores of TF clones and CI clones are 
indicated as pink and blue bars, respectively, with boxes representing the interquartile ranges, lines within boxes represent medians and whiskers 
represent minimum and maximum values
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with cell-surface receptors. Previous studies showed that 
gp120 protein stimulated MDDC ERK phosphorylation, 
impaired maturation of DCs and induced inflammation 
[37]. To investigate if PSV Env differentially activated 
MAPK signaling pathways, pERK levels were detected 
by WB after stimulation of MDDCs with C12, C13, C14, 
C15 and C16 PSVs. These clones were selected because 
they stimulated MDDCs to secrete different levels of 
cytokines and chemokines which might be reflected in 
changes in pERK levels. LPS was included as a positive 
control in this experiment because it has been shown to 
stimulate ERK phosphorylation [43]. PSV clones stimu-
lated an increase in pERK levels relative to the control, 
although only LPS induced pERK to statistically signifi-
cant levels (Fig. 5a). When we also employed flow cytom-
etry based analysis to follow Env-mediated increased 
protein phosphorylation in MDDCs, LPS, C12 and C13 
induced a twofold increase in phosphorylation of ERK 
and JNK over the control (data not shown). Therefore, 
although C13 PSV is a poor inducer of cytokine and 
chemokine secretion, it is able to stimulate both ERK and 
JNK phosphorylation. To confirm that Env was essen-
tial for the activation of ERK and JNK, purified gp140 
was used to stimulate MDDCs. C12 gp140 stimulated 
MDDCs to phosphorylate ERK and JNK similar to C12 
PSV although only LPS induced MDDCs to generate sig-
nificantly higher levels of pERK and pJNK compared to 
background (Fig. 5b, c). When C12 PSV DC-SIGN inter-
action was inhibited by recombinant DC-SIGN, MDDC 
pERK levels decreased significantly (Fig.  5d), suggesting 
that DC-SIGN interactions in part were contributing to 
ERK activation, in line with our findings regarding IL-10 
[34] and inflammatory cytokine secretion (Fig. 4). There-
fore, the ability of C12 PSV and gp140 to induce MDDC 
activation of ERK and JNK may in part involve interac-
tions between DC-SIGN and Env although we cannot 
rule out the influence of other DC receptors.
Therefore, Env and DC-SIGN interactions are poten-
tially involved in both the activation of ERK and the 
stimulation of MDDCs to release cytokines. However, 
a statistically significant correlation between the acti-
vation of MAPK signaling pathways and the extent to 
which clones induced the secretion of cytokines and 
chemokines was not observed. For example, C12 and C13 
PSV both induced the phosphorylation of ERK and JNK 
but only C12 induced significant increases in secretion of 
cytokine and chemokines by MDDC. It is thus possible 
that Env binding to DC-SIGN activates not only MAPKs 
Table 1 Factor loadings and unique variances of cytokines 
secreted by  the  MDDCs in  response to  pseudovirus 
stimulation
Factor loadings close to 1 indicate strong relatedness and very low values 
indicate uniqueness. Factor loadings greater than 0.6 (in italic) are considered for 
relatedness [42]
Variable Factor 1 Factor 2 Uniqueness
IL-10 0.9759 − 0.0451 0.0101
IL-6 0.9204 − 0.1996 0.0310
IL-1β 0.3595 0.7651 0.2693
TNF-α 0.9661 − 0.0845 0.0032
IL-12p40 0.2434 0.0772 0.5201
IL-8 0.4674 0.6360 0.3633
MIP-1α 0.9684 − 0.1779 0.0030
MIP-1β 0.9732 − 0.1125 − 0.0004
Fig. 3 Transmitted founder Envelopes induce more inflammatory immune response. Envelope clones (Env) were grouped according to time 
post-infection and the cytokine concentrations (pg/ml) secreted in response to transmitted founder (TF, grey bar) and chronic infection (CI, white 
bar) clones were compared to background. The fold change for each cytokine and chemokine above background for four biological repeats are 
indicated. Mann–Whitney t-test was used to compare the median value of the fold-change of cytokine concentration of four independent MDDC 
donors
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but also an unidentified signaling pathway(s) linked to 
cytokine secretion.
Discussion
Inflammation in the FGT is associated with increased 
risk of HIV infection, [44] multiple variant transmission, 
[2] and infection by less infectious virus [3]. However, the 
underlying mechanisms and causes of inflammation in a 
healthy genital mucosa are not fully understood. HIV may 
directly induce inflammatory responses needed to facili-
tate the establishment of infection [45] or inflammation 
may be pre-existing, caused by factors such as sexually 
transmitted infections (STIs) [2, 46] and dysbiosis [45]. In 
rhesus macaques, it has been shown that DCs play a criti-
cal role in the early stages of SIV infection by producing 
chemotactic cytokines that recruit CD4+ T cell targets 
for SIV infection [13]. It is thus possible that DCs play a 
similar role during the early stages of HIV infection. To 
investigate this, we compared inflammatory cytokine and 
chemokine production by MDDCs in response to pseu-
dotyped Env cloned longitudinally from women infected 
with a single HIV variant.
IL-10, MIP-1α, MIP 1β, IL-6, and IL-8 grouped 
together when exploratory factor analysis was used to 
classify the cytokines, suggesting their functions influ-
enced one another. It is tempting to consider that the 
observed DC IR might provide an advantage during 
transmission as three of the four clones that induced the 
release of high levels of cytokine were AI clones. Li et al. 
[3] found that a few days following macaque inoculation, 
pDCs just beneath the endocervix expressed high levels 
of MIP-1α, MIP-1β, MIP-3a, IFN-α and IFN-β and the 
chemokine levels were associated with enhanced SIV 
infection (13). Given their chemoattractant function it 
is possible that increased chemokine secretion helped 
to recruit CCR5 expressing cells to areas of infection, 
thereby facilitating viral replication. This was in fact seen 
with the influx of CD4+ cells to local infectious foci 
as early as 1–3  days post viral inoculation. Moreover, 
Fig. 4 Role of DC-SIGN in inducing MDDC inflammatory response. C12 and C13 pseudovirus (PSV) were pre-incubated in the presence and 
absence of recombinant DC-SIGN before stimulation of MDDCs. The concentrations of secreted TNF-α, IL-6, MIP-1α, MIP-1β and IL-8 were 
determined by Luminex assay. Wilcoxon Rank Signed test was used to compare the cytokine levels of four independent MDDC donors and error 
bars indicate the standard deviation (SD)
Page 8 of 13Lumngwena et al. Retrovirology           (2020) 17:17 
inhibition of inflammation by application of glycerol 
monolaurate significantly reduced target cells and inflam-
matory cytokines in the genital areas [13].
When matched pairs of Env were compared, the mean 
proinflammatory and chemokine scores for TFs were 
higher than those of CI clones. HIV-1 subtype C TF Env 
might have the advantage of skewing DC inflammatory 
responses in their favour to facilitate transmission. The 
in  vivo “cytokine storm” associated with acute HIV-1 
infection supports the suggestion that increased inflam-
matory responses favour viral replication most likely 
through the recruitment of HIV permissive cells [22, 
47]. However, this might not be true for all TFs, and the 
absence of this advantage might have consequences later 
during infection. Of note, the TF of the fourth matched 
pair, that did not induce an inflammatory cytokine pro-
file, was cloned from a slow progressor [48]. However, 
although it is tempting to speculate that TF variants have 
a selective advantage of inducing inflammatory responses 
in the FGT, our sample size is too small to reach definite 
conclusions.
The pathogenic products of Mycobacterium tubercu-
losis and HIV-1 (ManLAM and gp120 mannose resi-
dues, respectively) induced Raf-1 phosphorylation and 
activated Raf-1 promoted HIV-1 gene expression in 
DCs [36]. Gringhuis et al. [38, 49] found that binding of 
Fig. 5 HIV-1 Envelope induces MAPK activation. A) Following stimulation of day six MDDCs with pseudovirus generated with C12, C13, C14, C15 
and C16 Envelope (Env) clones, the phosphorylation of ERK was measured by Western blotting. Image J software was used to quantify band 
intensity and average intensity of at least four independent experiments are shown relative (%) to background signal (cells treated with pSG3ΔEnv 
only). Day six MDDCs were rested and stimulated with C12 (TF) gp140 and the phosphorylation of B) ERK and C) JNK was measured by flow 
cytometry. Flowjo software was used for analysis and mean fluorescent intensity (MFI) of two independent experiments are indicated relative 
(%) to background control (medium only), with error bars representing SD. D) MDDCs were stimulated with C12 PSV with (C12+) and without 
(C12) pre-incubation with anti-DC-SIGN monoclonal antibody and pERK levels were determined by Western blotting and expressed relative to 
background (%). Bar graphs indicate the mean of at least four independent experiments with error bars representing SD. A medium only (U) 
negative control and a lipopolysaccharide (LPS) positive control were included in each experiment. Mann–Whitney test (a, d) and one-way Anova 
(b, c) were used to compare means of pMAPK for both experiments
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ManLAM to DC-SIGN activated Raf-1 of the Ras-Raf-
MEK-MAPK pathway which resulted in NF-kB-stim-
ulated expression of cytokine genes, including IL-10. 
Furthermore, Env mediated activation of ERK1/2 and 
p38 MAPK differed between Env clones [39] suggesting 
that MAPK signalling via Raf-1 might be differentially 
activated by HIV-1 variants. To determine whether some 
Env were better able to activate MAPK, with concomi-
tant aberrant cytokine profiles, we determined whether 
the Env clones were able to stimulate the phosphoryla-
tion of MDDC ERK and JNK.
Following PSV and gp140 stimulation of MDDCs, we 
detected varied phosphorylation of the MAPKs across 
the clones. There was no overall significant correlation 
between MDDC cytokine secretion and ERK activation 
possibly due to the small sample size in conjunction with 
the high variation between MDDC donor responses. 
C13 consistently failed to induce MDDCs to secrete 
cytokines above that of background and yet this clone 
was able to stimulate ERK phosphorylation. Similarly, 
C16 PSV was also unable to stimulate MDDC inflamma-
tory response but did increase pERK levels. This suggests 
that cytokine secretion in response to HIV is modulated 
by more than one MDDC signalling mechanism. Block-
ing Env-DC-SIGN interaction inhibited cytokine release 
and ERK phosphorylation, demonstrating that DC-SIGN 
is involved in triggering the inflammatory response. We 
cannot exclude the possibility that recombinant soluble 
DC-SIGN and anti-DC-SIGN antibodies non-specifically 
inhibited MDDC signalling pathways independent of 
DC-SIGN and/or that Env binds to alternative receptors. 
However, we have reported that PSV bound Raji cells via 
DC-SIGN and MDDC-associated virus trans-infected 
TZM-bl cells, confirming Env and DC-SIGN interactions 
[34]. Furthermore, we showed that PSV binding to Raji-
DC-SIGN cells varied between clones, suggesting that 
differences in Env structure might influence the interac-
tion with DC-SIGN which could activate alternative sig-
nalling molecules. Variation in Env N-glycan structures 
do alter binding affinity to DC-SIGN which changes its 
ability to interact with more than one signalling mol-
ecule [50]. However, the mechanism of how this occurs 
remains unknown [51].
Conclusion
Although inflammation within the FGT is linked to 
HIV-1 infection [3, 52], the factors initiating the “cytokine 
storm” are unknown and may depend on several factors. 
Here we show that in the absence of pre-existing inflam-
mation, the virus itself could modulate MDDC inflam-
matory responses via its Env glycoprotein interaction 
with DC-SIGN. Furthermore, although based on a small 
sample size, single variant TF PSV tended to stimulate 
higher levels of inflammatory cytokines and chemokines 
compared to CI PSVs, suggesting that DC IR could play a 
role in HIV transmission.
Materials and methods
Samples
Full-length envelope (env) from four HIV positive 
women (CAP45, CAP206, CAP210 and CAP239) sam-
pled 2–5  weeks post-infection (wpi) (AI) with follow 
up longitudinal samples collected 2–3  years post infec-
tion (ypi) (CI) were used for this study (Table 1) (Acces-
sion numbers: JX976722.1, KC863497.1, FJ443390.1, 
47:KC833437.1, KJ700457.1, DQ435683.1, KC863280.1, 
KC863276.1, FJ443142.1, HQ625601, HQ625600.1, 
FJ443357.1, HQ625599.1, KC863388.1, HQ625599.1 
(www.ncbi.nlm.nih.gov). Single genome amplification 
(SGA) and sequencing indicated that all participants 
were infected with a single variant at transmission [5]. 
Nine functional Env clones (numbered C1, C2, C7, C8, 
and C12-C16), a subset of 36 generated from SGA—
derived PCR products, were cloned into pcDNA/his-
topo (Invitrogen) or pTarget (Promega) mammalian 
expression vectors according to manufacturer’s instruc-
tions. The functional clones selected in this study were 
sampled from four participants infected with a single 
variant at 2–5 wpi with follow-up 2–3 years later [5]. The 
CI clones (C2, C8, C13 and C14) were selected because 
they had N-glycosylation profiles identical to the con-
sensus sequence of circulating variants at CI. Potential 
N-glycosylation (PNG) frequency analysis was carried 
out on 36 matched Env consensus sequences from AI 
and CI (accession numbers: (JX976651.1, FJ443216.1, 
FJ443182.1, FJ443984.1, KC894137.1, KC863412.1, 
JN681229.1, KC863558.1, KC863493.1, KC863519.1, 
KC863542.1, KC833437.1, HQ625599.1, KC863410.1, 
JX976681.1, HQ625602.1, KC863457.1, HQ625605.1, 
FJ443279.1, FJ443963.1, KF996701.1) and random sub-
type C sequences (www.ncbi.nlm.nih.gov).
Cell culture
Human embryonic kidney (HEK) 293T and TZM-bl cells 
were maintained in Dulbecco modified Eagle high glu-
cose medium (DMEM) (Lonza, Whitehead Scientific). 
TZM-bl cells were obtained through the NIH AIDS Rea-
gent Program (ARP), Division of AIDS, NIAID from Dr. 
John C. Kappes, Dr. Xiaoyun Wu and Tranzyme Inc [53]. 
All cells were grown in a humidified incubator at 37  °C 
with 5%  CO2 and growth media were supplemented with 
10% fetal bovine serum (FBS) (PAA, Biocom Biotech), 1 
U/mL penicillin and 1 µg/mL streptomycin (P/S) (Lonza, 
Whitehead Scientific).
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Pseudovirus production
Pseudovirus (PSV) was prepared by co-transfection of 
HEK 293T cells with 2.5 µg of env and 5 µg of pSG3ΔEnv 
plasmids with PEI transfection reagent at a 1:3 DNA: PEI 
ratio. Culture medium was harvested 48 h later, filtered 
through a 0.22 µm pore sized filter and FBS was adjusted 
to 20% and stored at − 70 °C. The concentration of PSV 
was determined by a chemiluminescent ELISA (Aalto 
Bio-reagents) and  TROPIX® detection system (CDP-
Star®, Applied Biosystems). PSV titre was determined by 
infecting TZM-bl cells for 48 h with known p24 concen-
tration and relative luminescence units (RLU) were com-
pared between Env pseudotyped virus and pSG3ΔEnv 
PSV infected cells (background) and a titre resulting 
in 50 X RLU above background was used for MDDC 
stimulation.
Gp140 production from CHO cells
Full-length env was truncated before the transmembrane 
domain and gp140 was produced as described in Lumng-
wena et al. [34]. Briefly, Env was expressed in non-adher-
ent CHO cells to maximise expression while preserving 
N- glycosylation patterns introduced by HEK 293 cells 
[12]. Culture medium was harvested 72 h post-transfec-
tion and gp140 purified by affinity chromatography using 
Galanthus nivalis lectin Sepharose (Vector Labs, Burl-
ingame, CA) diluted fivefold with unliganded Sepharose 
4B (GE Healthcare) before dialysis with HEPES, pH 7.4, 
150 mM NaCl.
Generation of MDDC
Peripheral blood mononuclear cells (PBMC) were iso-
lated from buffy coats of healthy blood donors using 
Ficoll-Hypaque (Sigma-Aldrich). Monocytes isolated 
from PBMCs by positive selection using CD14+ coated 
beads (130-050-201 Miltenyi, USA or Biochom Biotech, 
S.A) were seeded in serum-free medium and allowed 
to adhere to tissue culture dishes for 2  h at 37  °C, 5% 
 CO2. Non-adherent cells were removed and differen-
tiation medium, supplemented with 1000 U/ml GM-
CSF (PHC2013, Biosource), and 500 U/ml recombinant 
human IL-4 (PHC0045, Biosource) was added to the cells 
and every other day for 6 days.
Monocyte derived dendritic cell stimulation
Either PSV (50X) or purified gp140 (2  µg/ml) was used 
to stimulate 2 × 106 cells/mL monocyte derived dendritic 
cells (MDDC) in 200 µl final volume of culture medium 
containing 2% AB human serum (H1513, Sigma), 1% P/S 
(Sigma Aldrich), 1% non-essential amino acids (Gibco-
Life technologies, USA), 1% sodium pyruvate (Gibco, 
USA) and 1% l-glutamine (Sigma Aldrich) in RPMI for 
24  h. Following stimulation, the plates were centrifuged 
at 2000  rpm for 10  min and the culture supernatants 
collected and stored at − 80℃. Prior to stimulation of 
MDDCs with PSV, MDDCs were pre-incubated with 
recombinant DC-SIGN (Donation from Dr Arthos) for 
1  h at ambient temperature in the presence of 2  mM 
 Ca2+, and then at 37 °C for an additional hour.
Purification of soluble DC‑SIGN
DC-SIGN was cloned into pET22b and expressed in E 
coli as inclusion bodies [54]. Recombinant DC-SIGN was 
refolded by rapid dilution in renaturation buffer (0.5  M 
Arginine, 5  mM Cysteamine, 1  mM Cystamine, 0.1  M 
Tris–HCl, pH 8.0) and purified by ion-exchange (15Q) 
and Superdex 200 HR size exclusion chromatography 
[54].
Luminex multiplex assay for cytokine quantification
The level of cytokines released by MDDCs into the 
culture supernatants was quantified using Luminex 
suspension array technology with cytokine-specific 
antibody-immobilized magnetic beads (Millipore, USA). 
Biotinylated secondary antibodies and streptavidin–
phycoerythrin conjugates were used to determine Mean 
Fluorescence Intensity (MFI) using a Luminex platform 
(Bio-rad, USA).
Phosphorylation of MAP Kinase
MDDCs were rested for 2  h, stimulated with pre-titred 
PSV or gp140 for 15  min, fixed with 2% paraformal-
dehyde in PBS, permeabilized and stained with fluo-
rescently conjugated antibodies to ERK and JNK and 
phosphorylation was detected by flow cytometry. Alter-
natively, phosphorylation of MAPKs was detected by 
Western blotting (WB). MDDCs were washed with pre-
warmed PBS and lysed (RIPA buffer containing protease 
and phosphatase inhibitors) after stimulation and 30 μg 
cell lysate was loaded per well for WB. DC-SIGN bind-
ing was inhibited by pre-incubation of MDDCs with 
anti-DC-SIGN Mab for 2 h at 37 °C (Clone DCN46, ARP 
7682).
Statistical analysis
Cytokine measurements (pg/ml) of at least 3 biological 
repeats were compared by Mann–Whitney test for non-
paired events and Wilcoxon matched test for pairwise 
comparison of paired events (GraphPad Prism 5.0). A P 
value < 0.05 was considered as statistically significant. 
P values were adjusted for multiple comparisons by the 
false discovery rate (FDR) step down procedure. Flow 
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cytometry raw data was analysed by Flowjo 9.6, while the 
intensity of WB bands was compared by densitometry 
analysis using the Image lab™ software on a Chemi  DocTm 
(Bio-rad) imaging system. Principal component analysis 
(PCA; in STATA™) was used to reduce the complexity 
of the dataset and to examine the relationship between 
PSV and different cytokine functions (chemokine and 
pro-inflammatory cytokines). Exploratory factor analy-
sis and unsupervised hierarchical clustering (in R) were 
used to determine the relatedness and uniqueness of the 
cytokines secreted. The cytokines secreted by MDDCs in 
response to PSV stimulation were scored in R using fac-
tor loading and the degree of variance between cytokines 
was determined by the eigenvalues. The principal factor 
method was used and the number of retained factors was 
determined using the Kaiser’s criterion.
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